InsidersTradesSigma
Track the 盘龙药业 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 盘龙药业 has logged 3 insider filings. Market capitalisation: €2.8bn. The latest transaction was disclosed on 12 March 2026 (Sale). Among the most active insiders: 朱文锋. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
盘龙药业 es una empresa que opera en el sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se centra en la investigación, desarrollo y producción de medicamentos innovadores.